Hi, what are you looking for?
– Pharmaceutical company Perrigo has yet to be sold and already major business publications are speculating on what its sale will mean to the TASE....
– The company is responsible for 10% of the trading turnover on the Tel Aviv 25 Index. /By Gali Weinreb and Tali Tsipori/ ...
– The pharmaceutical firm is seeking a merger at a good premium on its $20 billion market cap. – Sources inform “Globes” that pharmaceutical...
– Perrigo Company plc Announces Acquisition Of OTC Products In Australia – Perrigo Company plc (NYSE: PRGO;TASE) announced that it has acquired a basket...
– President and CEO Joseph C. Papa – Perrigo Company (NYSE:PRGO; TASE:PRGO) shareholders yesterday approved the acquisition of Ireland’s Elan Corporation plc (NYSE; LSE; Dublin:...
– Perrigo is acquiring Ireland’s Elan, a beneficiary of royalties from rival multiple sclerosis treatment, Tysabri. – – A safety warning by the US...
– Perrigo Initiates Nationwide Voluntary Product Recall Of Acetaminophen Infant Suspension Liquid, 160 mg/5 mL, Due To A Potential Defect With The Co-Packaged Oral...
– – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Perrigo Company (NYSE: PRGO;TASE) today announced the launch of the generic equivalent to Temodar (temozolomide)....
– There’s a lot happening in the pharmaceutical industry these days and one of the biggest deals so far this year will see US...
– The portfolio acquired from Fera, includes nine prescription products, and generated over $30 million net revenue in 2012. – – /By Shiri Habib-Valdhorn...